Advances in nanotechnology have favored the development of novel colloidal formulations
able to modulate the pharmacological and biopharmaceutical properties of drugs. The …

It has been frequently shown that nanoparticles are able to increase the efficiency of
antitumor drugs, decrease their side effects, and control distribution profile of drug …

The increase in cancer cases is undoubtedly affecting the development of new therapeutic
approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size …

Polymer-based nanoparticle-sustained drug delivery systems offer several advantages over
conventional delivery systems such as maintenance of optimum therapeutic concentration of …

The targeting of pharmaceuticals is a rapidly evolving strategy to overcome the difficulties in
therapeutic delivery, especially to the tumor site. Unlike traditional drug delivery systems …

In this review article we discuss some of the key aspects concerning the development of a
polymer-based nanoparticle formulation for intravenous drug delivery. Since numerous …

Nanomaterials can enhance the delivery and treatment efficiency of anti-cancer drugs, and
the mechanisms of the tumorreducing activity of nanomaterials with cancer drug have been …

Hydrophilic drug delivery still remains a challenge; this either being attributed to the fragility
and poor cellular penetration of macromolecules, or to the unsuitable pharmacokinetics and …

The current rapid advancement of numerous nanotechnology tools is being employed in
treatment of many terminal diseases such as cancer. Nanocapsules (NCs) containing an …

Promising results have come from attempts to direct drugs, nucleic acids and diagnostic
agents to tumours by using polymeric nanoparticles. Such carriers are versatile; their …